Astellas Pharma Us, Inc.Usage: Myrbetriq treats overactive bladder (OAB) in adults with urge urinary incontinence, urgency, and urinary frequency, alone or combined with solifenacin succinate. Also indicated for neurogenic detrusor overactivity (NDO) in pediatric patients aged 3 and older (Granules) or aged 3+ weighing 35 kg or more (tablets).